December 15th, 2015

This Life-Saving Breakthrough Is Saving COVID Patient’s Hearts and Giving You The Opportunity To Take Advantage Of A Projected $600 Billion Industry

For the last three years, Abiomed has grown earnings by 43% a year. At that rate, the company should double every 20 months.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.